TissGeneSummary for CEP170 |
Gene summary |
Basic gene information | Gene symbol | CEP170 |
Gene name | centrosomal protein 170kDa | |
Synonyms | FAM68A|KAB|KIAA0470 | |
Cytomap | UCSC genome browser: 1q44 | |
Type of gene | protein-coding | |
RefGenes | NM_001042404.1, NM_001042405.1,NM_014812.2, | |
Description | KARP-1-binding proteinXRCC5 binding proteincentrosomal protein of 170 kDa | |
Modification date | 20141207 | |
dbXrefs | MIM : 613023 | |
HGNC : HGNC | ||
Ensembl : ENSG00000143702 | ||
HPRD : 17172 | ||
Vega : OTTHUMG00000039862 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_CEP170 | |
BioGPS: 9859 | ||
Pathway | NCI Pathway Interaction Database: CEP170 | |
KEGG: CEP170 | ||
REACTOME: CEP170 | ||
Pathway Commons: CEP170 | ||
Context | iHOP: CEP170 | |
ligand binding site mutation search in PubMed: CEP170 | ||
UCL Cancer Institute: CEP170 | ||
Assigned class in TissGDB* | C | |
Included tissue-specific gene expression resources | ||
Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | Testis | |
Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | TGCT | |
Reference showing the relevant tissue of CEP170 | ||
Description by TissGene annotations | Cancer gene TissgsLTS Fused withOncogene Fused withTSGene |
* Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO term | PubMed ID |
Top |
TissGeneExp for CEP170 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
Gene expressions across normal tissues of GTEx data (GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1)) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
- Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
KIRC | 1.975220034 | 0.959475589 | 1.015744444 | 7.13E-26 | 9.24E-25 |
Top |
TissGene-miRNA for CEP170 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types (Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
Top |
TissGeneMut for CEP170 |
TissGeneSNV for CEP170 |
nsSNV counts per each loci. Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
- nsSNVs sorted by frequency. |
AAchange | Cancer type | # samples |
p.E539K | UCEC | 5 |
p.E539K | ESCA | 2 |
p.G1140R | BRCA | 1 |
p.D406H | BRCA | 1 |
p.S1177C | BLCA | 1 |
p.E417K | UCEC | 1 |
p.E505* | HNSC | 1 |
p.T640I | COAD | 1 |
p.E1167V | COAD | 1 |
p.I1400S | LGG | 1 |
p.R1054W | UCEC | 1 |
p.R643Q | BRCA | 1 |
p.R1448Q | SKCM | 1 |
p.Q785R | BRCA | 1 |
p.R1142* | UCEC | 1 |
p.E755K | STAD | 1 |
p.Q1044E | UCEC | 1 |
p.R37H | READ | 1 |
p.T565I | OV | 1 |
p.P171L | LUAD | 1 |
p.K1481R | UCEC | 1 |
p.R470K | BLCA | 1 |
p.D360V | LIHC | 1 |
p.E1577K | LUSC | 1 |
p.K308N | LUAD | 1 |
p.R1403W | STAD | 1 |
p.W1450C | LUAD | 1 |
p.R1357C | UCEC | 1 |
p.S1350Y | READ | 1 |
p.R393C | STAD | 1 |
p.S996F | SKCM | 1 |
p.R1208L | LUAD | 1 |
p.S5F | SKCM | 1 |
p.V363L | HNSC | 1 |
p.V361F | LUAD | 1 |
p.R1006C | UCEC | 1 |
p.A1502D | ESCA | 1 |
p.A591D | THYM | 1 |
p.L645H | SKCM | 1 |
p.A1562V | STAD | 1 |
p.Q783R | UCEC | 1 |
p.K987T | KIRP | 1 |
p.R1284G | COAD | 1 |
p.R431K | BLCA | 1 |
p.P1370S | SKCM | 1 |
p.V1358G | SKCM | 1 |
p.L1544F | BRCA | 1 |
p.S1087I | LUSC | 1 |
p.A423S | LUSC | 1 |
p.G574S | HNSC | 1 |
p.A169V | UCEC | 1 |
p.V584F | SKCM | 1 |
p.P180A | HNSC | 1 |
p.E513K | BLCA | 1 |
p.V1355G | ESCA | 1 |
p.D495E | HNSC | 1 |
p.S1085L | BLCA | 1 |
p.R545Q | COAD | 1 |
p.R1357C | SKCM | 1 |
p.R1448W | UCEC | 1 |
p.T682S | READ | 1 |
p.D318E | CESC | 1 |
p.R985K | LUAD | 1 |
p.R995C | SKCM | 1 |
p.K445R | UCEC | 1 |
p.D375N | CESC | 1 |
p.R20* | BLCA | 1 |
p.R1164C | LUAD | 1 |
p.S359I | ACC | 1 |
p.Y923H | UCEC | 1 |
p.H307Q | ESCA | 1 |
p.E558D | COAD | 1 |
p.P289S | SKCM | 1 |
p.S356R | PRAD | 1 |
p.G435C | LUAD | 1 |
p.R1014X | LIHC | 1 |
p.T458P | ESCA | 1 |
p.H1221D | CESC | 1 |
p.A659V | SKCM | 1 |
p.Y687C | LUAD | 1 |
p.S1133C | BLCA | 1 |
p.K542E | UCEC | 1 |
p.R349I | LUAD | 1 |
p.S1085L | CESC | 1 |
p.L346V | UCEC | 1 |
p.I272L | LIHC | 1 |
p.D1025N | BLCA | 1 |
p.T377K | THYM | 1 |
p.E102K | UCEC | 1 |
p.S785* | BLCA | 1 |
p.G1382S | STAD | 1 |
p.V486F | SKCM | 1 |
p.I1147V | BRCA | 1 |
p.T684A | UCEC | 1 |
p.S450L | UCEC | 1 |
p.R1154L | UCEC | 1 |
p.Q586H | LUSC | 1 |
p.P1246S | SKCM | 1 |
p.E417K | BRCA | 1 |
p.R995H | PAAD | 1 |
p.D1043N | LIHC | 1 |
p.S450L | COAD | 1 |
p.E1577K | STAD | 1 |
p.R909C | UCEC | 1 |
p.P171S | LUAD | 1 |
p.S566T | UCEC | 1 |
p.R626I | LUSC | 1 |
p.S724R | PRAD | 1 |
p.E513* | LUAD | 1 |
p.N508D | STAD | 1 |
p.P329R | BRCA | 1 |
p.I1206F | UCEC | 1 |
p.R388W | HNSC | 1 |
p.G439W | ACC | 1 |
p.K1155E | COAD | 1 |
p.T377M | LUAD | 1 |
p.R1403W | PRAD | 1 |
p.D1118A | LGG | 1 |
p.A1119V | UCEC | 1 |
p.P723S | COAD | 1 |
p.S452Y | UCEC | 1 |
p.R956* | OV | 1 |
p.E187D | KIRC | 1 |
p.S1279C | HNSC | 1 |
p.E507D | HNSC | 1 |
p.E1062D | KIRC | 1 |
p.I167T | UCEC | 1 |
p.S952T | KIRC | 1 |
p.T1090A | SKCM | 1 |
p.R172C | LUAD | 1 |
p.K246I | HNSC | 1 |
p.A757V | SKCM | 1 |
p.S464L | BLCA | 1 |
p.D998N | SKCM | 1 |
p.F606L | GBM | 1 |
p.D1290H | CESC | 1 |
p.S724C | LUAD | 1 |
p.Q1390* | CESC | 1 |
p.T1130A | LGG | 1 |
p.E206K | HNSC | 1 |
p.S466R | STAD | 1 |
p.T484P | STAD | 1 |
p.L32R | CESC | 1 |
p.A1119D | PRAD | 1 |
p.E679D | LUAD | 1 |
p.M1T | HNSC | 1 |
p.D1563Y | LUAD | 1 |
p.L720F | KIRP | 1 |
p.V1234G | SKCM | 1 |
p.T682A | UCEC | 1 |
p.L904I | UCEC | 1 |
p.R1299Q | LUAD | 1 |
p.R995H | LGG | 1 |
p.K409Q | UCEC | 1 |
p.A224V | TGCT | 1 |
p.Q753K | LUSC | 1 |
p.S415Y | UCEC | 1 |
p.S1207C | BLCA | 1 |
p.R37C | STAD | 1 |
p.V1355G | UCEC | 1 |
p.N1380K | STAD | 1 |
p.P683L | BLCA | 1 |
p.I1566V | HNSC | 1 |
Top |
TissGeneCNV for CEP170 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples) (TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
Top |
TissGeneFusions for CEP170 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
Chimerdb3.0 | FusionScan | LGG | TCGA-DU-6399-01A | CEP170-RAD51B | In-Frame | chr1:243349080 | chr14:68758600 |
Chimerdb3.0 | FusionScan | LGG | TCGA-S9-A6U6-01A | CEP170-RAD51B | In-Frame | chr1:243349080 | chr14:68758600 |
Chimerdb3.0 | FusionScan | LGG | TCGA-FG-A711-01A | CEP170-RAD51B | In-Frame | chr1:243349080 | chr14:68758600 |
Chimerdb3.0 | FusionScan | LGG | TCGA-HT-7485-01A | CEP170-RAD51B | In-Frame | chr1:243349080 | chr14:68758600 |
Chimerdb3.0 | FusionScan | LGG | TCGA-DU-A7TI-01A | CEP170-RAD51B | In-Frame | chr1:243349080 | chr14:68758600 |
Chimerdb3.0 | FusionScan | BRCA | TCGA-BH-A203-01A | CEP170-RAD51B | In-Frame | chr1:243349080 | chr14:68758600 |
Chimerdb3.0 | FusionScan | ESCA | TCGA-VR-A8EP-01A | CEP170-RAD51B | In-Frame | chr1:243349080 | chr14:68758600 |
Chimerdb3.0 | FusionScan | ESCA | TCGA-LN-A8HZ-01A | CEP170-RAD51B | In-Frame | chr1:243349080 | chr14:68758600 |
Chimerdb3.0 | FusionScan | ESCA | TCGA-LN-A5U5-01A | CEP170-RAD51B | In-Frame | chr1:243349080 | chr14:68758600 |
Chimerdb3.0 | FusionScan | ESCA | TCGA-Z6-A8JD-01A | CEP170-RAD51B | In-Frame | chr1:243349080 | chr14:68758600 |
Chimerdb3.0 | FusionScan | LUSC | TCGA-85-6798-01A | CEP170-RAD51B | In-Frame | chr1:243349080 | chr14:68758600 |
TCGAfusionPortal | PRADA | GBM | TCGA-06-2561-01A | CEP170-C1orf100 | CDS-5UTR | Chr1:243349561 | Chr1:244527990 |
TCGAfusionPortal | PRADA | HNSC | TCGA-BA-4074-01A | SDCCAG8-CEP170 | Out-of-frame | Chr1:243419542 | Chr1:243336148 |
TCGAfusionPortal | PRADA | LUAD | TCGA-44-8119-01A | CEP170-RGS7 | In-frame | Chr1:243385026 | Chr1:240990472 |
TCGAfusionPortal | PRADA | LUAD | TCGA-73-4662-01A | CEP170-SDCCAG8 | NA | Chr1:243418349 | Chr1:243468015 |
TCGAfusionPortal | PRADA | PRAD | TCGA-YL-A8HM-01A | CEP170-IFI16 | 5UTR-5UTR | Chr1:243418342 | Chr1:158979793 |
Top |
TissGeneNet for CEP170 |
Co-expressed gene networks based on protein-protein interaction data (CePIN) (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
Top |
TissGeneProg for CEP170 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
Top |
TissGeneClin for CEP170 |
TissGeneDrug for CEP170 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
TissGeneDisease for CEP170 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
Disease ID | Disease name | # pubmeds | Source |
umls:C0026769 | Multiple Sclerosis | 1 | GAD |
umls:C0040336 | Tobacco Use Disorder | 1 | GAD |